Commission Implementing Decision (EU) 2017/810 of 10 May 2017 on a derogation from mutual recognition of the authorisation of a biocidal product containing boric acid by France in accordance with Article 37 of Regulation (EU) No 528/2012 of the European Parliament and of the Council (notified under document C(2017) 2935)
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
1. The derogation from mutual recognition proposed by France for the product referred to in paragraph 2 is justified on the grounds of the protection of health and life of humans, particularly of vulnerable groups, as referred to in Article 37(1)(c) of Regulation (EU) No 528/2012. 2. Paragraph 1 applies to the product identified by the following case number, as provided for by the Register for Biocidal Products: BC-QC011565-51.
This Decision is addressed to the Republic of France.
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.